Diurnal variations are reported in pain perception, potency of placebo and
in the pharmacokinetics of morphine. It is not established if such diurnal
variation should be reflected in the routine prescription of analgesic drug
s to cancer patients. One approach for investigating this question is to st
udy the circadian rhythm of patients' requests for analgesics. We included
40 patients with malignant disease and intolerable pain despite treatment w
ith weak opioids. Weak opioids were stopped and the patients' pain treatmen
t was restricted for the next 2 days to strong oral opioids (ketobemidone)
given on an as-needed basis. The number and times of all ketobemidone admin
istrations were recorded. No significant diurnal variation in use of ketobe
midone was observed. A descriptive curve that interpolates between successi
ve observations displayed only slight circadian fluctuations of opioid cons
umption. Thus, the data reported in this paper does not support the necessi
ty of considering chronopharmacological factors in the routine prescription
of oral opioids. (C) 2000 Prous Science. All rights reserved.